Immunity products and China sales a major boost for Swisse-owner H&H as ANZ revenue plunges by a third
Swisse Wellness Careers and Employment | Indeed.com
Focus: Chinese baby product firms seek to age up, sell more abroad as population falls | Reuters
SP revenue license issuance temporarily suspended - NewsRadio - English
Overlooked ASX Cannabis Stock with a Global Revenue Footprint
Faulding taps Chinese vitamin boom after Blackmores, Swisse
H&H Group achieves 13.4% total revenue increase on a reported basis for the nine months to 30 September 2022, boosted by a strong third quarter
Daigou exodus hits Swisse vitamins in Australia
Disney Rethinks India Business Amid Revenue Slump, Losing IPL Rights
Biostime International Holdings Archives - Just Food
Inlight launches new Swisse.com.au - Inlight
Health Care Products Market Revenue Growth is Making
H&H Group to showcase China-focused wellness brand portfolio at Virtual travel Retail Expo : The Moodie Davitt Report -The Moodie Davitt Report
Elisa Nesta | LinkedIn
Swisse eyes resurgence after Covid-related sales slump - Inside FMCG
China's Biggest Health Supplements Winners on 6.18 2023 (with historical data) - TMO Group
Swisse and Biostime focus: H&H reveals global expansion drive for major brands as revenue grows 2.5%
Schweizer: Schweizer Electronic AG: Positive business development in the first quarter of 2023
BDA posts record breaking full year revenue, up 25%
George Livery, Swisse Wellness | PPT
Swiss biotech revenue 2015-2022 | Statista
Strong Australia and China sales propel Q3 revenue growth for Swisse
2022 Double 11: How did China's overseas health supplement market perform?
ncr-idpresentation2023
China's Biggest Health Supplements Winners on 6.18 2023 (with historical data) - TMO Group
credit swisse Annual Report Part 3 Financial report 1998 / | PDF
